Quantitative Evaluation of CFTR Pre-mRNA Splicing Dependent on the (TG)mTn Poly-Variant Tract

• Published in: Diagnostics (Basel) Vol. 11; no. 2; p. 168
• Main Authors: Sterrantino, Manuela, Fuso, Andrea, Pierandrei, Silvia, Bruno, Sabina Maria, Testino, Giancarlo, Cimino, Giuseppe, Angeloni, Antonio, Lucarelli, Marco
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.01.2021; MDPI
• Subjects: (TG)mTn tract; Calibration; CFTR-related disorders (CFTR-RD); Cystic Fibrosis; Cystic Fibrosis Transmembrane conductance Regulator (CFTR); Data analysis; Efficiency; functional effect of CFTR variants; Gene expression; Genotype & phenotype; Haplotypes; Plasmids; pre-mRNA splicing; Real time; United States > US; CFTR-related disorders (CFTR-RD); Cystic Fibrosis; (TG)mTn tract; functional effect of CFTR variants; nasal brushing; Cystic Fibrosis Transmembrane conductance Regulator (CFTR); real time; pre-mRNA splicing
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics11020168

Genetic analysis in cystic fibrosis (CF) is a difficult task. Within the many causes of variability and uncertainty, a major determinant is poor knowledge of the functional effect of most DNA variants of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene. In turn, knowledge of the effect of a CFTR variant has dramatic diagnostic, prognostic and, in the era of CF precision medicine, also therapeutic consequences. One of the most challenging CFTR variants is the (TG)mTn haplotype, which has variable functional effect and controversial clinical consequences. The exact quantification of the anomalous splicing of CFTR exon 10 (in the HGVS name; exon 9 in the legacy name) and, consequently, of the residual wild-type functional CFTR mRNA, should be mandatory in clinical assessment of patients with potentially pathological haplotype of this tract. Here, we present a real time-based assay for the quantification of the proportion of exon 10+/exon 10- CFTR mRNA, starting from nasal brushing. Our assay proved rapid, economic and easy to perform. Specific primers used for this assay are either disclosed or commercially available, allowing any laboratory to easily perform it. A simplified analysis of the data is provided, facilitating the interpretation of the results. This method helps to enhance the comprehension of the genotype-phenotype relationship in CF and CFTR-related disorders (CFTR-RD), crucial for the diagnosis, prognosis and personalized therapy of CF.